[ad_1]
To print this article, all you need is to be registered or login on Mondaq.com.
On January 3, the federal government opened the 118th Congress
– a group that will undoubtedly have a significant influence
over the future of the life sciences industry over the next several
years.
Our Trendspotting Report will help your company:
- Stay up to date on the latest legislative and policy
developments - Understand what these developments might mean for the life
sciences industry, including drug pricing and manufacturing
approaches - Be prepared to react, adapt, and thrive to whatever changes may
come
Our Life Sciences attorneys and government relations
professionals keep an ear to the ground of what’s happening on
Capitol Hill and the FDA and have close relationships with the
players influencing federal laws. We’ve gathered our insights
to help you position your company for success in 2023 and
beyond.
Download your Life Sciences Trendspotting 2023
Report >
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
[ad_2]
Source link
